Home
»
leyu.cim
»
Gene Therapy Market Size, Share & Growth Report, 2030

Gene Therapy Market Size, Share & Trends Report

Gene Therapy Market Size, Share & Trends Analysis Report By Indication (Acute Lymphoblastic Leukemia, Large B-cell Lymphoma), By Vector Type (Lentivirus), By Region, And Segment Forecasts, 2023 - 2030

Report ID: GVR-2-68038-179-5
Number of Pages: 170
Format: Electronic (PDF)

Historical Range: 2018 - 2021
Industry:Healthcare

Market Segmentation

Gene Therapy Indication Outlook (Revenue, USD Million, Number of Patients, 2018 - 2030)
- Acute Lymphoblastic Leukemia (ALL)
- Inherited Retinal Disease
- Large B-Cell Lymphoma
- ADA-SCID
- Melanoma (lesions)
- Beta-Thalassemia Major/SCD
- Head & Neck Squamous Cell Carcinoma
- Peripheral Arterial Disease
- Spinal Muscular Atrophy (SMA)
- Others
Gene Therapy Vector Type Outlook (Revenue, USD Million; 2018 - 2030)
- Lentivirus
- AAV
- RetroVirus & gamma RetroVirus
- Modified Herpes Simplex Virus
- Adenovirus
- Non-viral Plasmid Vector
- Others
Gene TherapyRegional Outlook (Revenue, USD Million, 2018 - 2030)
- North America
  - North America Gene Therapy market indication outlook (Revenue, USD Million, number of patients 2018 - 2030)
    - Acute Lymphoblastic Leukemia (ALL)
    - Inherited Retinal Disease
    - Large B-Cell Lymphoma
    - ADA-SCID
    - Melanoma (lesions)
    - Beta-Thalassemia Major/SCD
    - Head & Neck Squamous Cell Carcinoma
    - Peripheral Arterial Disease
    - Spinal Muscular Atrophy (SMA)
    - Others
  - North America Gene Therapy market vector type outlook (Revenue, USD Million, 2018 - 2030)
    - Lentivirus
    - AAV
    - RetroVirus & gamma RetroVirus
    - Modified Herpes Simplex Virus
    - Adenovirus
    - Non-viral Plasmid Vector
    - Others
  - U.S.
    - U.S. Gene Therapy market indication outlook (Revenue, USD Million, number of patients, 2018 - 2030)
      - Acute Lymphoblastic Leukemia (ALL)
      - Inherited Retinal Disease
      - Large B-Cell Lymphoma
      - ADA-SCID
      - Melanoma (lesions)
      - Beta-Thalassemia Major/SCD
      - Head & Neck Squamous Cell Carcinoma
      - Peripheral Arterial Disease
      - Spinal Muscular Atrophy (SMA)
      - Others
    - U.S. Gene Therapy market vector type outlook (Revenue, USD Million, 2018 - 2030)
      - Lentivirus
      - AAV
      - RetroVirus & gamma RetroVirus
      - Modified Herpes Simplex Virus
      - Adenovirus
      - Non-viral Plasmid Vector
      - Others
  - Canada
    - Canada Gene Therapy market indication outlook (Revenue, USD Million, number of patients, 2018 - 2030)
      - Acute Lymphoblastic Leukemia (ALL)
      - Inherited Retinal Disease
      - Large B-Cell Lymphoma
      - ADA-SCID
      - Melanoma (lesions)
      - Beta-Thalassemia Major/SCD
      - Head & Neck Squamous Cell Carcinoma
      - Peripheral Arterial Disease
      - Spinal Muscular Atrophy (SMA)
      - Others
    - Canada Gene Therapy market vector type outlook (Revenue, USD Million, 2018 - 2030)
      - Lentivirus
      - AAV
      - RetroVirus & gamma RetroVirus
      - Modified Herpes Simplex Virus
      - Adenovirus
      - Non-viral Plasmid Vector
      - Others
- Europe
  - Europe Gene Therapy market indication outlook (Revenue, USD Million, number of patients, 2018 - 2030)
    - Acute Lymphoblastic Leukemia (ALL)
    - Inherited Retinal Disease
    - Large B-Cell Lymphoma
    - ADA-SCID
    - Melanoma (lesions)
    - Beta-Thalassemia Major/SCD
    - Head & Neck Squamous Cell Carcinoma
    - Peripheral Arterial Disease
    - Spinal Muscular Atrophy (SMA)
    - Others
  - Europe Gene Therapy market vector type outlook (Revenue, USD Million, 2018 - 2030)
    - Lentivirus
    - AAV
    - RetroVirus & gamma RetroVirus
    - Modified Herpes Simplex Virus
    - Adenovirus
    - Non-viral Plasmid Vector
    - Others
  - Germany
    - Germany Gene Therapy market indication outlook (Revenue, USD Million, number of patients, 2018 - 2030)
      - Acute Lymphoblastic Leukemia (ALL)
      - Inherited Retinal Disease
      - Large B-Cell Lymphoma
      - ADA-SCID
      - Melanoma (lesions)
      - Beta-Thalassemia Major/SCD
      - Head & Neck Squamous Cell Carcinoma
      - Peripheral Arterial Disease
      - Spinal Muscular Atrophy (SMA)
      - Others
    - Germany Gene Therapy market vector type outlook (Revenue, USD Million, 2018 - 2030)
      - Lentivirus
      - AAV
      - RetroVirus & gamma RetroVirus
      - Modified Herpes Simplex Virus
      - Adenovirus
      - Non-viral Plasmid Vector
      - Others
  - UK
    - UK Gene Therapy market indication outlook (Revenue, USD Million, number of patients, 2018 - 2030)
      - Acute Lymphoblastic Leukemia (ALL)
      - Inherited Retinal Disease
      - Large B-Cell Lymphoma
      - ADA-SCID
      - Melanoma (lesions)
      - Beta-Thalassemia Major/SCD
      - Head & Neck Squamous Cell Carcinoma
      - Peripheral Arterial Disease
      - Spinal Muscular Atrophy (SMA)
      - Others
    - UK Gene Therapy market vector type outlook (Revenue, USD Million, 2018 - 2030)
      - Lentivirus
      - AAV
      - RetroVirus & gamma RetroVirus
      - Modified Herpes Simplex Virus
      - Adenovirus
      - Non-viral Plasmid Vector
      - Others
  - France
    - France Gene Therapy market indication outlook (Revenue, USD Million, number of patients, 2018 - 2030)
      - Acute Lymphoblastic Leukemia (ALL)
      - Inherited Retinal Disease
      - Large B-Cell Lymphoma
      - ADA-SCID
      - Melanoma (lesions)
      - Beta-Thalassemia Major/SCD
      - Head & Neck Squamous Cell Carcinoma
      - Peripheral Arterial Disease
      - Spinal Muscular Atrophy (SMA)
      - Others
    - France Gene Therapy market vector type outlook (Revenue, USD Million, 2018 - 2030)
      - Lentivirus
      - AAV
      - RetroVirus & gamma RetroVirus
      - Modified Herpes Simplex Virus
      - Adenovirus
      - Non-viral Plasmid Vector
      - Others
  - Italy
    - Italy Gene Therapy market indication outlook (Revenue, USD Million, number of patients, 2018 - 2030)
      - Acute Lymphoblastic Leukemia (ALL)
      - Inherited Retinal Disease
      - Large B-Cell Lymphoma
      - ADA-SCID
      - Melanoma (lesions)
      - Beta-Thalassemia Major/SCD
      - Head & Neck Squamous Cell Carcinoma
      - Peripheral Arterial Disease
      - Spinal Muscular Atrophy (SMA)
      - Others
    - Italy Gene Therapy market vector type outlook (Revenue, USD Million, 2018 - 2030)
      - Lentivirus
      - AAV
      - RetroVirus & gamma RetroVirus
      - Modified Herpes Simplex Virus
      - Adenovirus
      - Non-viral Plasmid Vector
      - Others
  - Spain
    - Spain Gene Therapy market indication outlook (Revenue, USD Million, number of patients, 2018 - 2030)
      - Acute Lymphoblastic Leukemia (ALL)
      - Inherited Retinal Disease
      - Large B-Cell Lymphoma
      - ADA-SCID
      - Melanoma (lesions)
      - Beta-Thalassemia Major/SCD
      - Head & Neck Squamous Cell Carcinoma
      - Peripheral Arterial Disease
      - Spinal Muscular Atrophy (SMA)
      - Others
    - Spain Gene Therapy market vector type outlook (Revenue, USD Million, 2018 - 2030)
      - Lentivirus
      - AAV
      - RetroVirus & gamma RetroVirus
      - Modified Herpes Simplex Virus
      - Adenovirus
      - Non-viral Plasmid Vector
      - Others
- Asia Pacific
  - Asia Pacific Gene Therapy market indication outlook (Revenue, USD Million, number of patients, 2018 - 2030)
    - Acute Lymphoblastic Leukemia (ALL)
    - Inherited Retinal Disease
    - Large B-Cell Lymphoma
    - ADA-SCID
    - Melanoma (lesions)
    - Beta-Thalassemia Major/SCD
    - Head & Neck Squamous Cell Carcinoma
    - Peripheral Arterial Disease
    - Spinal Muscular Atrophy (SMA)
    - Others
  - Asia Pacific Gene Therapy market vector type outlook (Revenue, USD Million, 2018 - 2030)
    - Lentivirus
    - AAV
    - RetroVirus & gamma RetroVirus
    - Modified Herpes Simplex Virus
    - Adenovirus
    - Non-viral Plasmid Vector
    - Others
  - China
    - 中国基因治疗市场前景迹象(梦nue, USD Million, number of patients, 2018 - 2030)
      - Acute Lymphoblastic Leukemia (ALL)
      - Inherited Retinal Disease
      - Large B-Cell Lymphoma
      - ADA-SCID
      - Melanoma (lesions)
      - Beta-Thalassemia Major/SCD
      - Head & Neck Squamous Cell Carcinoma
      - Peripheral Arterial Disease
      - Spinal Muscular Atrophy (SMA)
      - Others
    - China Gene Therapy market vector type outlook (Revenue, USD Million, 2018 - 2030)
      - Lentivirus
      - AAV
      - RetroVirus & gamma RetroVirus
      - Modified Herpes Simplex Virus
      - Adenovirus
      - Non-viral Plasmid Vector
      - Others
  - Japan
    - Japan Gene Therapy market indication outlook (Revenue, USD Million, number of patients, 2018 - 2030)
      - Acute Lymphoblastic Leukemia (ALL)
      - Inherited Retinal Disease
      - Large B-Cell Lymphoma
      - ADA-SCID
      - Melanoma (lesions)
      - Beta-Thalassemia Major/SCD
      - Head & Neck Squamous Cell Carcinoma
      - Peripheral Arterial Disease
      - Spinal Muscular Atrophy (SMA)
      - Others
    - Japan Gene Therapy market vector type outlook (Revenue, USD Million, 2018 - 2030)
      - Lentivirus
      - AAV
      - RetroVirus & gamma RetroVirus
      - Modified Herpes Simplex Virus
      - Adenovirus
      - Non-viral Plasmid Vector
      - Others
  - India
    - India Gene Therapy market indication outlook (Revenue, USD Million, number of patients, 2018 - 2030)
      - Acute Lymphoblastic Leukemia (ALL)
      - Inherited Retinal Disease
      - Large B-Cell Lymphoma
      - ADA-SCID
      - Melanoma (lesions)
      - Beta-Thalassemia Major/SCD
      - Head & Neck Squamous Cell Carcinoma
      - Peripheral Arterial Disease
      - Spinal Muscular Atrophy (SMA)
      - Others
    - India Gene Therapy market vector type outlook (Revenue, USD Million, 2018 - 2030)
      - Lentivirus
      - AAV
      - RetroVirus & gamma RetroVirus
      - Modified Herpes Simplex Virus
      - Adenovirus
      - Non-viral Plasmid Vector
      - Others
  - Australia
    - Australia Gene Therapy market indication outlook (Revenue, USD Million, number of patients, 2018 - 2030)
      - Acute Lymphoblastic Leukemia (ALL)
      - Inherited Retinal Disease
      - Large B-Cell Lymphoma
      - ADA-SCID
      - Melanoma (lesions)
      - Beta-Thalassemia Major/SCD
      - Head & Neck Squamous Cell Carcinoma
      - Peripheral Arterial Disease
      - Spinal Muscular Atrophy (SMA)
      - Others
    - Australia Gene Therapy market vector type outlook (Revenue, USD Million, 2018 - 2030)
      - Lentivirus
      - AAV
      - RetroVirus & gamma RetroVirus
      - Modified Herpes Simplex Virus
      - Adenovirus
      - Non-viral Plasmid Vector
      - Others
- Rest Of The World

Report Content

Qualitative Analysis

Industry overview
Industry trends
Market drivers and restraints
乐鱼体育手机网站入口
Growth prospects
Porter’s Five Forces analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments

Quantitative Analysis

Market size, estimates, and forecast from 2018 to 2030
Market estimates and forecast for product segments up to 2030
Regional market size and forecast for product segments up to 2030
Market estimates and forecast for application segments up to 2030
Regional market size and forecast for application segments up to 2030
Company financial performance

GET A FREE SAMPLE

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

Or view our licence options:

NEED A CUSTOM REPORT?

We can customize every report -free of charge- including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

ESOMAR certified & member

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read ourprivacy policy.